sponsored
PatientsVille.com Logo

PatientsVille

Lorazepam and Lisinopril

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectLorazepamLisinopril
NAUSEA3.3% 3.3%
DRUG INEFFECTIVE2.6% 3.2%
FATIGUE3% 3.1%
DIARRHOEA2.5% 2.8%
DYSPNOEA2.3% 2.7%
DIZZINESS2% 2.5%
PAIN1.8% 2.2%
VOMITING2.2% 1.8%
HEADACHE2% 2.1%
ANXIETY2.1% 1.1%
ASTHENIA1.7% 1.9%
FALL1.9% 1.6%
COMPLETED SUICIDE1.8% 0.6%
DRUG INTERACTION1.7% 0.7%
INSOMNIA1.6% 1.2%
DEATH1.6% 1.1%
DEPRESSION1.6% 1.1%
MALAISE1.5% 1.5%
WEIGHT DECREASED1.2% 1.5%
PNEUMONIA1.5% 1.2%
ARTHRALGIA1% 1.5%
PYREXIA1.5% 0.9%
COUGH0.8% 1.5%
SOMNOLENCE1.5% 0.7%
PAIN IN EXTREMITY1% 1.4%
HYPERTENSION1% 1.4%
MYOCARDIAL INFARCTION0.6% 1.4%
HYPOTENSION1.3% 1.3%
OFF LABEL USE1.3% 1.2%
RASH1.1% 1.3%
CONFUSIONAL STATE1.3% 0.8%
PRURITUS0.8% 1.3%
TOXICITY TO VARIOUS AGENTS1.3% 0.4%
ANGIOEDEMA0% 1.3%
CHEST PAIN0.9% 1.2%
BLOOD GLUCOSE INCREASED0% 1.2%
BACK PAIN1% 1.1%
CONSTIPATION1.1% 1%
TREMOR1.1% 0.7%
DRUG DOSE OMISSION0.6% 1.1%
OVERDOSE1.1% 0%
CARDIAC FAILURE CONGESTIVE0% 1.1%
FEELING ABNORMAL1% 1%
DECREASED APPETITE1% 1%
DEHYDRATION1% 1%
WEIGHT INCREASED1% 0.9%
ANAEMIA0.9% 1%
ABDOMINAL PAIN1% 0.9%
CONDITION AGGRAVATED1% 0.7%
RENAL FAILURE0.7% 1%
BLOOD PRESSURE INCREASED0.6% 1%
CEREBROVASCULAR ACCIDENT0.5% 1%
AGITATION1% 0%
FLUSHING0% 1%
DRUG ABUSE1% 0%
GAIT DISTURBANCE0.9% 0.9%
MUSCLE SPASMS0.7% 0.9%
ACUTE KIDNEY INJURY0.6% 0.9%
DRUG HYPERSENSITIVITY0% 0.9%
SUICIDE ATTEMPT0.9% 0%
ABDOMINAL PAIN UPPER0.8% 0.8%
URINARY TRACT INFECTION0.8% 0.7%
OEDEMA PERIPHERAL0.7% 0.8%
PARAESTHESIA0.7% 0.8%
LOSS OF CONSCIOUSNESS0.8% 0.6%
MYALGIA0.6% 0.8%
RENAL FAILURE ACUTE0% 0.8%
TACHYCARDIA0.8% 0%
GASTROINTESTINAL HAEMORRHAGE0% 0.8%
HYPOAESTHESIA0.6% 0.7%
ALOPECIA0.6% 0.7%
HYPERHIDROSIS0.7% 0.6%
ABDOMINAL DISCOMFORT0.5% 0.7%
ATRIAL FIBRILLATION0.5% 0.7%
SUICIDAL IDEATION0.7% 0%
INTENTIONAL OVERDOSE0.7% 0%
CARDIAC ARREST0.7% 0%
SOPOR0.7% 0%
INJECTION SITE PAIN0% 0.7%
HAEMOGLOBIN DECREASED0.6% 0.5%
DYSPHAGIA0.6% 0.5%
SYNCOPE0.5% 0.6%
VISION BLURRED0.5% 0.6%
MUSCULAR WEAKNESS0.5% 0.6%
NEUTROPENIA0.6% 0%
SEPSIS0.6% 0%
HYPONATRAEMIA0.6% 0%
ERYTHEMA0% 0.6%
PRODUCT QUALITY ISSUE0% 0.6%
NASOPHARYNGITIS0% 0.6%
PERIPHERAL SWELLING0% 0.6%
CHRONIC KIDNEY DISEASE0% 0.6%
COMA0.6% 0%
PULMONARY EMBOLISM0.6% 0%
CONVULSION0.6% 0%
CONTUSION0.5% 0.5%
HEART RATE INCREASED0.5% 0.5%
MEMORY IMPAIRMENT0.5% 0.5%
DIABETES MELLITUS0.5% 0.5%
PALPITATIONS0.5% 0.5%
CHILLS0.5% 0.4%
HALLUCINATION0.5% 0%
URTICARIA0% 0.5%
GASTROOESOPHAGEAL REFLUX DISEASE0% 0.5%
JOINT SWELLING0% 0.5%
CORONARY ARTERY DISEASE0% 0.5%
HYPERKALAEMIA0% 0.5%
DYSPEPSIA0% 0.5%
INCORRECT DOSE ADMINISTERED0% 0.5%
HYPERSENSITIVITY0% 0.5%
RESPIRATORY FAILURE0.5% 0%
GENERAL PHYSICAL HEALTH DETERIORATION0.5% 0%
DELIRIUM0.5% 0%
THROMBOCYTOPENIA0.5% 0%
PLATELET COUNT DECREASED0.5% 0%
WHITE BLOOD CELL COUNT DECREASED0.5% 0%
DRUG WITHDRAWAL SYNDROME0.5% 0%
AGGRESSION0.5% 0%
NEUROLEPTIC MALIGNANT SYNDROME0.5% 0%
PLEURAL EFFUSION0.5% 0%
CARDIO-RESPIRATORY ARREST0.5% 0%
BALANCE DISORDER0% 0.4%
DYSGEUSIA0% 0.4%
BRONCHITIS0% 0.4%
NEUROPATHY PERIPHERAL0% 0.4%
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION0% 0.4%
CHRONIC OBSTRUCTIVE PULMONARY DISEASE0% 0.4%

New treatments are found every day. View current Lorazepam research studies and Lisinopril clinical trials

1